Rehabilitation Program Dedicated to Post-stroke Lateropulsion Including Exoskeleton Assisted Exercises
EXOLAT
2 other identifiers
interventional
3
1 country
2
Brief Summary
Lateropulsion is a deficit in the body orientation with respect to the vertical in the coronal plane, defined by the presence of one of the three signs: lateral body tilt, active pushing from the sound limbs, and resistance to passive corrections. The lateral body tilt is the cardinal sign, the frequency of the 2 other signs increasing with lateropulsion severity (most dramatic forms called pusher syndrome in the past). Lateropulsion is frequent after stroke, and represents the main factor underpinning balance and gait disorders at the subacute phase. After hemisphere stroke lateropulsion is caused by a bias in the internal model of the verticality in the frontal plane, individuals unconsciously aligning their body posture on a tilted verticality representation. Pilot studies suggested the possibility to recalibrate the internal model of verticality, biased by stroke, and to improve individuals' uprightness. The investigators expect that a specific rehabilitation program combining technics devoted to lateropulsion, and comprising exoskeleton (Atalante) assisted balance exercises could help recalibrate the internal model of verticality and alleviate lateropulsion. The primary objective is to test the hypothesis that a 3-week specific lateropulsion rehabilitation program (15 sessions of 30 minutes including exoskeleton and a rehabilitation focused on the vertical body orientation in the frontal plane) improves the visual vertical (VV), the most used test to assess verticality perception.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2025
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 22, 2025
CompletedFirst Posted
Study publicly available on registry
June 17, 2025
CompletedStudy Start
First participant enrolled
June 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2026
June 17, 2025
June 1, 2025
1 year
April 22, 2025
June 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual Vertical (VV) Orientation
VV consists in testing the direction of a visual line, perceived as vertical by participants, in complete darkness. VV will be tested by a well-validated apparatus and paradigm (Pérennou et al Brain 2008 ; Piscicelli \& Pérennou 2017). VV orientation will be the average orientation (in degree) of the 10 trials performed. Higher score means a worse outcome, indicating the magnitude of the bias in verticality perception.
Daily, from enrollment to the end of treatment at 8 weeks
Secondary Outcomes (15)
Postural Vertical (PV) orientation and uncertainty
Once a week from enrollment to the end of program at 8 weeks
Lateropulsion severity assessed by SCALA
once a week from enrollment to the end of treatment at 8 weeks
Lateropulsion severity assessed by SCP
once a week from enrollment to the end of treatment at 8 weeks
Visual Vertical Uncertainty
Daily, from enrollment to the end of treatment at 8 weeks
specific post-effect of one exoskeleton session on visual vertical
once a week during the 3 lateropulsion program weeks
- +10 more secondary outcomes
Study Arms (3)
program week 2-3-4
EXPERIMENTALFor the participant included in this arm, the intervention will take place during weeks 2-3-4 (5 times per week 30-min sessions with specific physiotherapy targeting lateropulsion including exercices in exoskeleton + 5 times per week conventional physiotherapy). During weeks 1, 5, 6, 7 \& 8, 30-min sessions of conventional physiotherapy will take place 10 times per week. The rest of the rehabilitation (speech therapy, neuropsychology, occupational therapy) will be provided as usual.
program week 3-4-5
EXPERIMENTALFor the participant included in this arm, the intervention will take place during weeks 3-4-5 (5 times per week 30-min sessions with specific physiotherapy targeting lateropulsion including exercices in exoskeleton + 5 times per week conventional physiotherapy). During weeks 1, 2, 6, 7 \& 8, 30-min sessions of conventional physiotherapy will take place 10 times per week. The rest of the rehabilitation (speech therapy, neuropsychology, occupational therapy) will be provided as usual.
program week 4-5-6
EXPERIMENTALFor the participant included in this arm, the intervention will take place during weeks 4-5-6 (5 times per week 30-min sessions with specific physiotherapy targeting lateropulsion including exercices in exoskeleton + 5 times per week conventional physiotherapy). During weeks 1, 2, 3, 7 \& 8, 30-min sessions of conventional physiotherapy will take place 10 times per week. The rest of the rehabilitation (speech therapy, neuropsychology, occupational therapy) will be provided as usual.
Interventions
5 times a week during 30 minutes sessions = 15 Physiotherapy sessions, focused on the active vertical body orientation in the frontal plane and comprising exoskeleton-assisted balance and gait exercises. \+ 5 times a week during 30 minutes sessions = 15 conventional physiotherapy without exercises dedicated to lateropulsion or verticality representation alleviation The intervention description is more extensive in the study description section
10 times a week, during 30-minutes
Eligibility Criteria
You may qualify if:
- Right hemispheric first and unique ischemic stroke between 2 weeks and 6 months old (subacute phase) ;
- Presence of lateropulsion, assessed by the Scale for Contraversive Pushing (2 ≤ SCP \< 5)
- Presence of contralesional VV bias (VV \> 4°)
- Right handedness defined by a Edinburgh score ≥0,39
- Being hospitalized in a Physical Medicine and Neurological Rehabilitation (PMR) facility.
- Have given a written and informed consent
You may not qualify if:
- Medical instability making evaluation impossible,
- Comprehension or cognitive or behavioral disorders, or depressive symptoms that compromise participation in the program
- Postural disorders or body geometry disorders that interfere with balance for a reason that is independant of the stroke
- Morphological contraindications to the use of the Atalante® robot (segment length or joint ranges; height \<155cm; weight \>100kg),
- Severe spasticity (\>3 on the modified Ashworth scale) in the adductors, quadriceps, hamstrings and triceps surae
- Presence of a pressure sore at the areas of contact with the Atalante® robot,
- History of osteoporotic fractures.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Grenoble University Hospital
Échirolles, France
Grenoble University Hospital
Grenoble, 38043, France
Related Publications (26)
Yun N, Joo MC, Kim SC, Kim MS. Robot-assisted gait training effectively improved lateropulsion in subacute stroke patients: a single-blinded randomized controlled trial. Eur J Phys Rehabil Med. 2018 Dec;54(6):827-836. doi: 10.23736/S1973-9087.18.05077-3. Epub 2018 Dec 3.
PMID: 30507899BACKGROUNDWinstein CJ, Stein J, Arena R, Bates B, Cherney LR, Cramer SC, Deruyter F, Eng JJ, Fisher B, Harvey RL, Lang CE, MacKay-Lyons M, Ottenbacher KJ, Pugh S, Reeves MJ, Richards LG, Stiers W, Zorowitz RD; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Quality of Care and Outcomes Research. Guidelines for Adult Stroke Rehabilitation and Recovery: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2016 Jun;47(6):e98-e169. doi: 10.1161/STR.0000000000000098. Epub 2016 May 4.
PMID: 27145936BACKGROUNDPiscicelli C, Perennou D. Visual verticality perception after stroke: A systematic review of methodological approaches and suggestions for standardization. Ann Phys Rehabil Med. 2017 Jun;60(3):208-216. doi: 10.1016/j.rehab.2016.02.004. Epub 2016 Apr 11.
PMID: 27079584BACKGROUNDPerennou DA, Mazibrada G, Chauvineau V, Greenwood R, Rothwell J, Gresty MA, Bronstein AM. Lateropulsion, pushing and verticality perception in hemisphere stroke: a causal relationship? Brain. 2008 Sep;131(Pt 9):2401-13. doi: 10.1093/brain/awn170. Epub 2008 Aug 4.
PMID: 18678565BACKGROUNDPerennou DA, Amblard B, Leblond C, Pelissier J. Biased postural vertical in humans with hemispheric cerebral lesions. Neurosci Lett. 1998 Aug 14;252(2):75-8. doi: 10.1016/s0304-3940(98)00501-1.
PMID: 9756325BACKGROUNDPaci M, Macchioni G, Ferrarello F. Treatment approaches for pusher behaviour: a scoping review. Top Stroke Rehabil. 2023 Mar;30(2):119-136. doi: 10.1080/10749357.2021.2016098. Epub 2022 Feb 14.
PMID: 35156566BACKGROUNDOdin A, Faletto-Passy D, Assaban F, Perennou D. Modulating the internal model of verticality by virtual reality and body-weight support walking: A pilot study. Ann Phys Rehabil Med. 2018 Sep;61(5):292-299. doi: 10.1016/j.rehab.2018.07.003. Epub 2018 Jul 19.
PMID: 30031891BACKGROUNDNolan J, Jacques A, Godecke E, Abe H, Babyar S, Bergmann J, Birnbaum M, Dai S, Danells C, Edwards TG, Gandolfi M, Jahn K, Koter R, Mansfield A, Nakamura J, Pardo V, Perennou D, Piscicelli C, Punt D, Romick-Sheldon D, Saeys W, Smania N, Vaes N, Whitt AL, Singer B. Clinical practice recommendations for management of lateropulsion after stroke determined by a Delphi expert panel. Clin Rehabil. 2023 Nov;37(11):1559-1574. doi: 10.1177/02692155231172012. Epub 2023 Apr 26.
PMID: 37122265BACKGROUNDLouie DR, Mortenson WB, Durocher M, Schneeberg A, Teasell R, Yao J, Eng JJ. Efficacy of an exoskeleton-based physical therapy program for non-ambulatory patients during subacute stroke rehabilitation: a randomized controlled trial. J Neuroeng Rehabil. 2021 Oct 10;18(1):149. doi: 10.1186/s12984-021-00942-z.
PMID: 34629104BACKGROUNDLewis J, Heinemann T, Jacques A, Chan K, Harper KJ, Nolan J. Lateropulsion is a predictor of falls during inpatient stroke rehabilitation. Ann Phys Rehabil Med. 2024 Mar;67(2):101814. doi: 10.1016/j.rehab.2023.101814. Epub 2024 Mar 20. No abstract available.
PMID: 38513306BACKGROUNDKrewer C, Riess K, Bergmann J, Muller F, Jahn K, Koenig E. Immediate effectiveness of single-session therapeutic interventions in pusher behaviour. Gait Posture. 2013 Feb;37(2):246-50. doi: 10.1016/j.gaitpost.2012.07.014. Epub 2012 Aug 11.
PMID: 22889929BACKGROUNDHsu TH, Tsai CL, Chi JY, Hsu CY, Lin YN. Effect of wearable exoskeleton on post-stroke gait: A systematic review and meta-analysis. Ann Phys Rehabil Med. 2023 Feb;66(1):101674. doi: 10.1016/j.rehab.2022.101674. Epub 2022 Nov 30.
PMID: 35525427BACKGROUNDFukata K, Amimoto K, Inoue M, Shida K, Kurosawa S, Inoue M, Fujino Y, Makita S, Takahashi H. Effects of performing a lateral-reaching exercise while seated on a tilted surface for severe post-stroke pusher behavior: A case series. Top Stroke Rehabil. 2021 Dec;28(8):606-613. doi: 10.1080/10749357.2020.1861718. Epub 2020 Dec 20.
PMID: 33345722BACKGROUNDDieterich M, Brandt T. Wallenberg's syndrome: lateropulsion, cyclorotation, and subjective visual vertical in thirty-six patients. Ann Neurol. 1992 Apr;31(4):399-408. doi: 10.1002/ana.410310409.
PMID: 1586141BACKGROUNDDanells CJ, Black SE, Gladstone DJ, McIlroy WE. Poststroke "pushing": natural history and relationship to motor and functional recovery. Stroke. 2004 Dec;35(12):2873-8. doi: 10.1161/01.STR.0000147724.83468.18. Epub 2004 Nov 4.
PMID: 15528459BACKGROUNDDai S, Piscicelli C, Clarac E, Baciu M, Hommel M, Perennou D. Balance, Lateropulsion, and Gait Disorders in Subacute Stroke. Neurology. 2021 Apr 27;96(17):e2147-e2159. doi: 10.1212/WNL.0000000000011152. Epub 2020 Nov 11.
PMID: 33177223BACKGROUNDDai S, Lemaire C, Piscicelli C, Perennou D. Lateropulsion Prevalence After Stroke: A Systematic Review and Meta-analysis. Neurology. 2022 Apr 12;98(15):e1574-e1584. doi: 10.1212/WNL.0000000000200010. Epub 2022 Feb 21.
PMID: 35190465BACKGROUNDCalabro RS, Sorrentino G, Cassio A, Mazzoli D, Andrenelli E, Bizzarini E, Campanini I, Carmignano SM, Cerulli S, Chisari C, Colombo V, Dalise S, Fundaro C, Gazzotti V, Mazzoleni D, Mazzucchelli M, Melegari C, Merlo A, Stampacchia G, Boldrini P, Mazzoleni S, Posteraro F, Benanti P, Castelli E, Draicchio F, Falabella V, Galeri S, Gimigliano F, Grigioni M, Mazzon S, Molteni F, Morone G, Petrarca M, Picelli A, Senatore M, Turchetti G, Bonaiuti D; Italian Consensus Conference on Robotics in Neurorehabilitation (CICERONE). Robotic-assisted gait rehabilitation following stroke: a systematic review of current guidelines and practical clinical recommendations. Eur J Phys Rehabil Med. 2021 Jun;57(3):460-471. doi: 10.23736/S1973-9087.21.06887-8. Epub 2021 May 5.
PMID: 33947828BACKGROUNDBrandt T, Dieterich M, Danek A. Vestibular cortex lesions affect the perception of verticality. Ann Neurol. 1994 Apr;35(4):403-12. doi: 10.1002/ana.410350406.
PMID: 8154866BACKGROUNDBergmann J, Krewer C, Jahn K, Muller F. Robot-assisted gait training to reduce pusher behavior: A randomized controlled trial. Neurology. 2018 Oct 2;91(14):e1319-e1327. doi: 10.1212/WNL.0000000000006276. Epub 2018 Aug 31.
PMID: 30171076BACKGROUNDBarra J, Marquer A, Joassin R, Reymond C, Metge L, Chauvineau V, Perennou D. Humans use internal models to construct and update a sense of verticality. Brain. 2010 Dec;133(Pt 12):3552-63. doi: 10.1093/brain/awq311. Epub 2010 Nov 19.
PMID: 21097492BACKGROUNDBaier B, Suchan J, Karnath HO, Dieterich M. Neural correlates of disturbed perception of verticality. Neurology. 2012 Mar 6;78(10):728-35. doi: 10.1212/WNL.0b013e318248e544. Epub 2012 Feb 22.
PMID: 22357719BACKGROUNDBaggio JA, Mazin SS, Alessio-Alves FF, Barros CG, Carneiro AA, Leite JP, Pontes-Neto OM, Santos-Pontelli TE. Verticality Perceptions Associate with Postural Control and Functionality in Stroke Patients. PLoS One. 2016 Mar 8;11(3):e0150754. doi: 10.1371/journal.pone.0150754. eCollection 2016.
PMID: 26954679BACKGROUNDBabyar SR, Peterson MG, Reding M. Time to recovery from lateropulsion dependent on key stroke deficits: a retrospective analysis. Neurorehabil Neural Repair. 2015 Mar-Apr;29(3):207-13. doi: 10.1177/1545968314541330. Epub 2014 Jul 8.
PMID: 25009223BACKGROUNDAn CM, Ko MH, Kim DH, Kim GW. Effect of postural training using a whole-body tilt apparatus in subacute stroke patients with lateropulsion: A single-blinded randomized controlled trial. Ann Phys Rehabil Med. 2021 Mar;64(2):101393. doi: 10.1016/j.rehab.2020.05.001. Epub 2020 Oct 14.
PMID: 32450273BACKGROUNDAbe H, Kondo T, Oouchida Y, Suzukamo Y, Fujiwara S, Izumi S. Prevalence and length of recovery of pusher syndrome based on cerebral hemispheric lesion side in patients with acute stroke. Stroke. 2012 Jun;43(6):1654-6. doi: 10.1161/STROKEAHA.111.638379. Epub 2012 Mar 1.
PMID: 22382159BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dominic Pérennou, MD, PhD, Pr
University Hospital, Grenoble
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 22, 2025
First Posted
June 17, 2025
Study Start
June 20, 2025
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
September 30, 2026
Last Updated
June 17, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR
- Time Frame
- After seminal publication of the results
- Access Criteria
- Anonymized data that support the findings of this study will be available from the principal investigator (Pr Dominic Pérennou), upon reasonable request, only for authorized research. Their use is subjected to an agreement with the promotor (CHU Grenoble) and the principal investigator of the EXOLAT study
Anonymized data that support the findings of this study will be available from the principal investigator (Pr Dominic Pérennou), upon reasonable request, only for authorized research. Their use is subjected to an agreement with the promotor (CHU Grenoble) and the principal investigator of the EXOLAT study